These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 7819538)

  • 1. Low dopamine transporter mRNA levels in midbrain regions containing calbindin.
    Sanghera MK; Manaye KF; Liang CL; Lacopino AM; Bannon MJ; German DC
    Neuroreport; 1994 Aug; 5(13):1641-4. PubMed ID: 7819538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopamine transporter mRNA levels are high in midbrain neurons vulnerable to MPTP.
    Sanghera MK; Manaye K; McMahon A; Sonsalla PK; German DC
    Neuroreport; 1997 Oct; 8(15):3327-31. PubMed ID: 9351666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Midbrain dopaminergic neurons in the mouse that contain calbindin-D28k exhibit reduced vulnerability to MPTP-induced neurodegeneration.
    Liang CL; Sinton CM; Sonsalla PK; German DC
    Neurodegeneration; 1996 Dec; 5(4):313-8. PubMed ID: 9117542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroactive peptides exist in the midbrain dopaminergic neurons that contain calbindin-D28k.
    German DC; Liang CL
    Neuroreport; 1993 May; 4(5):491-4. PubMed ID: 8513124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subsets of midbrain dopaminergic neurons in monkeys are distinguished by different levels of mRNA for the dopamine transporter: comparison with the mRNA for the D2 receptor, tyrosine hydroxylase and calbindin immunoreactivity.
    Haber SN; Ryoo H; Cox C; Lu W
    J Comp Neurol; 1995 Nov; 362(3):400-10. PubMed ID: 8576447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Midbrain dopaminergic cell loss in Parkinson's disease and MPTP-induced parkinsonism: sparing of calbindin-D28k-containing cells.
    German DC; Manaye KF; Sonsalla PK; Brooks BA
    Ann N Y Acad Sci; 1992 May; 648():42-62. PubMed ID: 1353337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Midbrain dopaminergic neurons in the mouse: co-localization with Calbindin-D28K and calretinin.
    Liang CL; Sinton CM; German DC
    Neuroscience; 1996 Nov; 75(2):523-33. PubMed ID: 8931015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vulnerability of midbrain dopaminergic neurons in calbindin-D28k-deficient mice: lack of evidence for a neuroprotective role of endogenous calbindin in MPTP-treated and weaver mice.
    Airaksinen MS; Thoenen H; Meyer M
    Eur J Neurosci; 1997 Jan; 9(1):120-7. PubMed ID: 9042576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The neurotoxin MPTP increases calbindin-D28k levels in mouse midbrain dopaminergic neurons.
    Ng MC; Iacopino AM; Quintero EM; Marches F; Sonsalla PK; Liang CL; Speciale SG; German DC
    Brain Res Mol Brain Res; 1996 Mar; 36(2):329-36. PubMed ID: 8965654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Co-expression of dopamine transporter mRNA and tyrosine hydroxylase mRNA in ventral mesencephalic neurones.
    Augood SJ; Westmore K; McKenna PJ; Emson PC
    Brain Res Mol Brain Res; 1993 Dec; 20(4):328-34. PubMed ID: 7906851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tyrosine hydroxylase and dopamine transporter expression in residual dopaminergic neurons: potential contributors to spontaneous recovery from experimental Parkinsonism.
    Rothblat DS; Schroeder JA; Schneider JS
    J Neurosci Res; 2001 Aug; 65(3):254-66. PubMed ID: 11494360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential expression of tyrosine hydroxylase and membrane dopamine transporter genes in subpopulations of dopaminergic neurons of the rat mesencephalon.
    Blanchard V; Raisman-Vozari R; Vyas S; Michel PP; Javoy-Agid F; Uhl G; Agid Y
    Brain Res Mol Brain Res; 1994 Mar; 22(1-4):29-38. PubMed ID: 7912404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calbindin-D28k-containing neurons in the human hypothalamus: relationship to dopaminergic neurons.
    Sanghera MK; Zamora JL; German DC
    Neurodegeneration; 1995 Dec; 4(4):375-81. PubMed ID: 8846230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sparing of the dopaminergic neurons containing calbindin-D28k and of the dopaminergic mesocortical projections in weaver mutant mice.
    Gaspar P; Ben Jelloun N; Febvret A
    Neuroscience; 1994 Jul; 61(2):293-305. PubMed ID: 7969910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased susceptibility to oxidative stress underlies the resistance of specific dopaminergic cell populations to paraquat-induced degeneration.
    McCormack AL; Atienza JG; Langston JW; Di Monte DA
    Neuroscience; 2006 Aug; 141(2):929-937. PubMed ID: 16677770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopamine transporter mRNA: dense expression in ventral midbrain neurons.
    Shimada S; Kitayama S; Walther D; Uhl G
    Brain Res Mol Brain Res; 1992 May; 13(4):359-62. PubMed ID: 1352613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perinatal delta9-tetrahydrocannabinol exposure did not alter dopamine transporter and tyrosine hydroxylase mRNA levels in midbrain dopaminergic neurons of adult male and female rats.
    García-Gil L; Ramos JA; Rubino T; Parolaro D; Fernández-Ruiz JJ
    Neurotoxicol Teratol; 1998; 20(5):549-53. PubMed ID: 9761594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Localization of calcium-binding proteins and GABA transporter (GAT-1) messenger RNA in the human subthalamic nucleus.
    Augood SJ; Waldvogel HJ; Münkle MC; Faull RL; Emson PC
    Neuroscience; 1999 Jan; 88(2):521-34. PubMed ID: 10197772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The neonatal ventral hippocampal lesion model of schizophrenia: effects on dopamine and GABA mRNA markers in the rat midbrain.
    Lipska BK; Lerman DN; Khaing ZZ; Weinberger DR
    Eur J Neurosci; 2003 Dec; 18(11):3097-104. PubMed ID: 14656305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential modification of dopamine transporter and tyrosine hydroxylase mRNAs in midbrain of subjects with Parkinson's, Alzheimer's with parkinsonism, and Alzheimer's disease.
    Joyce JN; Smutzer G; Whitty CJ; Myers A; Bannon MJ
    Mov Disord; 1997 Nov; 12(6):885-97. PubMed ID: 9399211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.